Li-Kuo Su, Editor-in-Chief of Cancer Cell will join us at the Hotel Alimara, Monday 14 January 2013, 09:00 – 10:15, to deliver the 5th in VHIO´s prestigious series of VHIO Meet the Editors talks:
Cancer Cell and the Cancer Research Community
Related Posts
VHIO Spin-Off Mosaic Biomedicals co-recipient of CataloniaBio´s Biosuccess Award of the Year
Wednesday night´s annual Night of CataloniaBio gala event convening some 250 entrepreneurs, executives, investors, and leading scientists from within the…
17 Mar 2017
Notch not only in cancer: VHIO´s María Abad describes the power of Notch inhibition in enhancing cardiac reprogramming
María Abad, who joined VHIO last summer from the Department of Molecular Biology, the University of Texas Southwestern Medical Center,…
07 Mar 2017
Trio of VHIO talents awarded by AECC for research aimed at advancing cancer science and novel therapeutic approaches
Earlier this month the Spanish Association against Cancer (AECC) announced the results of its most recent Call. Among the awarded…
21 Jul 2017
VI Annual FERO Grant to support 3D study of tumor DNA
This year´s annual Fero Foundation (Fundación de Investigación Oncológica) Grant for Translational Research, amounting to 70,000 EUR was presented Monday 12 May, to Sandra Peiró for a two year research project aimed at determining the three-dimensional structure of the tumor cell genome with emphasis on tumor progression and metastatis.
15 May 2014
An Interview with Ana Vivancos, PI of VHIO´s Cancer Genomics Group: Biomarker anlayses in emerging data from P13K/AKT/mTOR program clinical trials
At the recent IMPAKT Breast Cancer Conference, 2 – 4th May, Brussels, ecancer´s Peter Goodwin talks to Ana Vivancos about…
22 May 2013
In partnership with leading organisations across the globe AECC declares 24 September as World Cancer Research Day
Today, a special roundtable, presided by Her Majesty Queen Letizia of Spain, President of the Spanish Association Against Cancer (AECC),…
22 Sep 2016
VHIO joins 13 partner-strong consortium aimed at combating colorectal cancer
Announced today by lead partner Queen´s University Belfast, Northern Ireland, UK, a new European Consortium MErCuRIC comprised of 13 globally…
11 Dec 2013
VHIO Meet the Editors with AACR´s Cancer Discovery – the new "kid on the block"
Taking place on Monday 24 February 2014, 09:15 – 10:30, we are delighted to advance that Executive Editor of Cancer…
14 Nov 2013
First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment
• The new study published in Cancer Discovery, the flagship journal of the American Association of Cancer Research (AACR), involving…
24 Feb 2013
PLoS One: Vitamin D Receptor Deficiency Enhances Wnt/ß-Catenin Signaling and Tumor Burden in Colon Cancer
CONFIRMATION THAT VITAMIN D ACTS AS A PROTECTIVE AGENT AGAINST THE ADVANCE OF COLON CANCER A study conducted by…
16 Aug 2011
VHIO awarded International Certification for Project Management in Cancer Biomedical Research
Fulfilling the requirements of the standard ISO 9001:2008, VHIO is one of the few research institutes in Europe to have…
06 Jun 2013
VHIO´s Enriqueta Felip receives Merck´s Grant for Oncology Innovation for novel blood-based approach towards more precisely guiding treatment with immunotherapy
Officially announced during this month´s annual Congress of the European Society of Medical Oncology (ESMO), 07 – 11 October in…
18 Oct 2016
VHIO´s Joan Seoane elected as Fellow of the prestigious European Academy of Cancer Sciences
Launched back in 2009, the European Academy of Cancer Sciences, presided by Alexander M.M. Eggermont, also Director General of Gustave…
16 Oct 2017
Advancements in resistance to Tamoxifen
Antonio Hurtado, from the Cambridge Research Institute, will offer a seminar on the factors that cause resistance to Tamoxifen on breast cancer patients
07 Sep 2010
Biosimilars create opportunities for sustainable cancer care
Source: the European Society for Medical Oncology (ESMO) Lugano, Switzerland, 18 January, 2017 – Biosimilars create opportunities for sustainable cancer…
18 Jan 2017
